Mesoblast (MESO) Research & Development (2015 - 2023)

Mesoblast has disclosed Research & Development across 9 years of filings, most recently posting -$2.6 billion for Q2 2023.

• Research & Development for Q2 2023 came in at -$2.6 billion, up 0.75% year-over-year; the trailing twelve-month figure through Jun 2023 was -$809.1 million (down 642.2% YoY), and the FY2025 annual result was $34.8 million, down 12.36% from the prior year.
• Research & Development came in at -$2.6 billion for Q2 2023 at Mesoblast, down from $1.0 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.6 billion in Q1 2021 to a low of -$6.6 billion in Q2 2021.
• The 5-year median for Research & Development is $479.5 million (2019), against an average of -$297.2 million.
• Across the five-year window, Research & Development plunged 16992.02% in 2020 and jumped 5698.1% in 2021, its largest moves.
• Mesoblast's Research & Development stood at $650.5 million in 2019, then plunged by 102.19% to -$14.2 million in 2020, then surged by 5698.1% to $797.1 million in 2021, then fell by 6.61% to $744.4 million in 2022, then plunged by 454.5% to -$2.6 billion in 2023.
• The last three Research & Development figures came in at -$2.6 billion (Q2 2023), $1.0 billion (Q1 2023), and $744.4 million (Q4 2022), per Business Quant data.